Register | Login

Patients for individualized clinical decision-making would fill an unmet clinical need. Activating somatic KRAS mutations are nearly omnipresent and a hallmark in the genetic make-up of pancreatic ductal adenocarcinoma (PDAC) [5]. While KRAS mutations themselves have been associated as prognostic markers, there is considerable and significant heterogeneity in the activation states of the downstrea

Who Voted for this Story




High PR Social Bookmarking Sites List 2018

Username:

Password:

Remember:
Saved Stories